Evidence map›Paper›PMID 32479524›Full record

ArticlePloS one2020

Fortifier selection and dosage enables control of breast milk osmolarity.

Ana Herranz Barbero, Nayra Rico, Benjamí Oller-Salvia, Victoria Aldecoa-Bilbao, Laura Macías-Muñoz, Robin Wijngaard, Josep Figueras-Aloy, MªDolors Salvia-Roigés

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Osmolality of fortified human milk with contemporary human milk fortifiers.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana Herranz BarberoNeonatology Deparment, BCNatal-Barcelona Center for Maternal Fetal and Neonatal Medicine, Hospital Clínic-Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.ORCID 0000-0003-1010-4295
Nayra RicoCore Laboratory, Clínic Hospital, University of Barcelona, Barcelona, Spain.
Benjamí Oller-SalviaInstitut Químic de Sarrià, Universitat Ramon Llull, Barcelona, Spain.
Victoria Aldecoa-BilbaoNeonatology Deparment, BCNatal-Barcelona Center for Maternal Fetal and Neonatal Medicine, Hospital Clínic-Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
Laura Macías-MuñozCore Laboratory, Clínic Hospital, University of Barcelona, Barcelona, Spain.
Robin WijngaardCore Laboratory, Clínic Hospital, University of Barcelona, Barcelona, Spain.
Josep Figueras-AloyNeonatology Deparment, BCNatal-Barcelona Center for Maternal Fetal and Neonatal Medicine, Hospital Clínic-Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
MªDolors Salvia-RoigésNeonatology Deparment, BCNatal-Barcelona Center for Maternal Fetal and Neonatal Medicine, Hospital Clínic-Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman breast milk (BM) fortification is required to feed preterm newborns with less than 32 weeks of gestation. However, addition of fortifiers increases osmolarity and osmolarity values higher than 450 mOsm/kg may be related to gastrointestinal pathology. Hence, fortifier selection and dosage are key to achieve optimal feeding.

objectivesTo compare the effect on osmolality of adding different fortifications, including recently developed formulations, to BM and to study evolution of osmolarity over time in supplemented BM.

methodsFrozen mature BM from 10 healthy mothers of premature newborns was fortified with each of the following human milk fortifiers (HMF): AlmirónFortifier®, NANFM85®, or PreNANFM85®. In addition, fortified BMs were modified with one of the following nutritional supplements (NS): Duocal MCT®, Nutricia® AminoAcids Mix, or Maxijul®. Osmolality of BM alone, fortified and/or supplemented was measured at 1 and 22 hours after their preparation. All samples were kept at 4°C throughout the study.

resultsOsmolality of BM alone was close to 300 mOsm/kg and did not change over 22 hours. When equicaloric amounts of HMF AlmirónFortifier®, NANFM85®, and PreNANFM85® were added to BM, osmolality increased roughly to 480 mOsm/kg with the first two fortifiers and only to 433±6 mOsm/kg with the third one. Upon addition of any of four different NSs to BM modified with AlmirónFortifier® and NANFM85®, osmolality reached values greater than 520 mOsm/kg, while osmolality of PreNANFM85® with two out of the four NSs remained below 490 mOsm/kg. NSs supplementing carbohydrates and hydrolysed proteins resulted into a higher increase of BM osmolarity. Osmolality increased significantly with time and, after 22h, only BM modified with PreNANFM85® remained below 450 mOsm/kg.

conclusionsUpon addition of the HMFs tested, BM osmolality increases significantly and keeps raising over time. All HMFs but the recently developed PreNAN FM85® at 4% exceed the AAP recommended threshold for osmolarity of 450 mOsm/kg. Addition of NSs to PreNAN FM85® at 4% significantly increases osmolality above 450 mOsm/Kg. Thus, using PreNAN FM85® at 5% may be preferable to adding nutritional supplements since nutritional recommendations by the ESPGHAN are reached with a lower increase in osmolality.

Indexed as

Food, FortifiedInfant Nutritional Physiological PhenomenaAdultFemaleHumansInfant, NewbornInfant, PrematureMilk, HumanNutrientsOsmolar ConcentrationNutrients

Identifiers

PMID32479524
PMCPMC7263599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.